Ravel Biotechnology markets an analytic technology platform capable of early detection of disease from cell-free DNA.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: San Francisco
State: California
Zip:
Country: United States
Ravel Biotechnology markets an analytic technology platform capable of early detection of disease from cell-free DNA. The technology platform enables the accelerated development and validation of screening tests for a wide range of diseases from a single analyte, cell-free DNA. Thus providing the opportunity to screen for a multitude of diseases from a single blood draw. The company was co-founded by Erik Gafni and Nathan Boley in 2018 and is based in San Francisco, California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2019 | Seed Round | 1 | - |
rocketship.vc rocketship.vc |
1/2020 | Venture Round | 1 | - |
Hemi Ventures Hemi Ventures |
1/2020 | Venture Round | 1 | - |
Hemi Ventures Hemi Ventures |
8/2019 | Seed Round | 1 | - |
rocketship.vc rocketship.vc |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|